medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2010, Number 07

<< Back Next >>

Ginecol Obstet Mex 2010; 78 (07)

Laparoscopic radical hysterectomy with lymphatic mapping and sentinel lymph node biopsy in early cervical cancer

Maffuz A, Quijano F, López D, Hernández-Ramírez D

Language: Spanish
References: 19
Page: 345-351
PDF size: 316.79 Kb.


ABSTRACT

Background: in patients with early-stage cervical cancer (FIGO IA, IB2 and IIA), the incidence of lymph node metastases is up to 15%; the majority of early cervical cancer patients with pelvic and para-aortic lymphadenectomy does not benefit with the procedure and are at risk of associated morbidity (linfocyst, lymphedema, vascular or nerve damage).
Objective: To describe the experience and usefulness of lymphatic mapping and sentinel lymph node with total laparoscopic radical hysterectomy in early stage cervical cancer.
Patients and method: Retrospective study in patients with diagnosis of cervical cancer in early stage, submitted to laparoscopic radical hysterectomy with lymphatic mapping and sentinel lymph node biopsy. We analyzed sentinel lymph node identification, false negative rate and surgical variables.
Results: in 36 months 15 patients were included, two in IA2 FIGO stage, twelve IB1 and one IIA; thirteen patients were mapping with combined technique and two only with dye. The sentinel lymph node identification rate was 87% (two failures in the patients using only blue dye); the false negative rate was 0%.
Conclusion: Laparoscopic radical hysterectomy with lymphatic mapping is a secure technique for patients with early stage cervical cancer; it allows the correct identification of lymph node status as the principal prognostic factor. We recommend the use of combined technique (radiocolloid tracer and blue dye) for best rate sentinel lymph node identification.


REFERENCES

  1. Spirtos NM, Schlaerth JB, Gross GM, Spirtos TW, et al. Cost and quality-of-life analyses of surgery for early endometrial cancer: laparotomy versus laparoscopy. Am J Obstet Gynecol 1996;174:1795-1799.

  2. Piver MS, Rutledge FN, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974;44:265-272.

  3. Dargent D, Enria R. Laparoscopic assessment of the sentinel lymph nodes in early cervical cancer. Technique-preliminary results and future developments. Crit Rev Oncol Hematol 2003;48(3):305-310.

  4. Martínez-Palones JM, Gil-Moreno A, Pérez-Benavente MA, Roca I, Xercavins J. Intraoperative sentinel node identification in early stage cervical cancer using a combination of radiolabeled albumin injection and isosulfan blue dye injection. Gynecol Oncol 2004;92(3):845-850.

  5. Leong SP, Donegan E, Heffernon W, Dean S, Katz JA. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol 2000;7(5):361-366.

  6. Montgomery LL, Thorne AC, Van Zee KJ, Fey J, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg 2002;95(2):385-388.

  7. Sadiq TS, Burns WW 3rd, Taber DJ, Damitz L, Ollila DW. Blue urticaria: a previously unreported adverse event associated with isosulfan blue. Arch Surg 2001;136(12):1433-1435.

  8. Cimmino VM, Brown AC, Szocik JF, Pass HA, et al. Allergic reactions to isosulfan blue during sentinel node biopsy. A common event. Surgery 2001;130(3):439-442.

  9. Maffuz A, Cortés G, López D, Quijano F. Laparoscopia para la etapificación y el tratamiento del cáncer cervicouterino. Ginecol Obstet Mex 2009;77(5):213-218.

  10. Vieira SC, Sousa RB, Tavares MBAC, Silva JB, et al. Preoperative pelvic lymphoscintigraphy is of limited usefulness for sentinel lymph node detection in cervical cancer. Eur J Obstet Gynecol Reprod Biol 2009;145:96-99.

  11. Frumovitz M, Ramírez PT, Levenback CF. Lymphatic mapping and sentinel lymph node detection in women with cervical cancer. Gynecol Oncol 2008;110:S17-S20.

  12. Marnitz S, Köhler C, Bongardt S, Braig U, et al. Topographic distribution of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol 2006;103:35-44.

  13. Dargent D, Enria R. Laparoscopic assessment of the sentinel lymph nodes in early cervical cancer. Technique-Preliminary results and future developments. Crit Rev Oncol Haematol 2003;48:305-310.

  14. Buist MR, Pijpers RJ, van Lingen A, van Diest PJ, et al. Laparoscopic detection of sentinel lymph nodes followed by lymph node dissection in patients with early stage cervical cancer. Gynecol Oncol 2003;90:290-296.

  15. Levenback C, Coleman RL, Burke TW, Lin WM, et al. Lymphatic mapping and sentinel lymph node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol 2002;20:688-693.

  16. O’Boyle JD, Coleman RL, Bernstein SG, Lifshitz S, et al. Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: a pilot study. Gynecol Oncol 2000;79:238-243.

  17. Schneider A, Hertel H. Surgical and radiographic staging in patients with cervical cancer. Curr Opin Obstet Gynecol 2004;16:11-18.

  18. Torné A, Puig-Tintoré LM. The use of sentinel lymph nodes in gynaecological malignancies. Curr Opin Obstet Gynecol 2004;16:57-64.

  19. El-Ghobashy AE, Saidi SA. Sentinel lymph node sampling in gynaecological cancers: Techniques and clinical applications. Eur J Surg Oncol 2009;35:675-685.




2020     |     www.medigraphic.com